Remove 2005 Remove Intellectual Property Remove Invention Remove Patent Infringement
article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

SpicyIP

Several intellectual property rights battles are being fought over this new technology. COVID-19 Vaccine Patent Infringement? In their initial August 2022 complaint , Moderna alleged that three of its mRNA patents were infringed by Pfizer/BioNTech. Moderna’s first infringement claim: Patent no. ’574

article thumbnail

Claim Construction Order Sets Stage for Moderna v. Pfizer Vaccine Patent Showdown

Patently-O

by Dennis Crouch Moderna filed a patent infringement lawsuit against Pfizer and BioNTech in August 2022, alleging that the defendants COVID-19 vaccine infringes three patents related to Moderna’s mRNA vaccine technology. United States Patent Nos. 2005) (en banc). 10,898,574, 10,702,600, and 10,933,127.

Patent 97
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Some Concerns about the Amendment Process to Key Patent Levers: A “Captured” Patent Office?

SpicyIP

This report which is mandated under American law and placed before the US Congress, requires the USTR to conduct a review of the intellectual property (IP) laws and enforcement policies of American trading partners in order to identify those laws or practices which maybe detrimental to American interests.

Patent 52
article thumbnail

Biogen Seeks a Preliminary Injunction in Natalizumab BPCIA Case Against Sandoz

LexBlog IP

Biogen alleges infringement of twenty-eight patents under the BPCIA based on Sandoz’s submission of an aBLA for PB006, a proposed biosimilar of TYSABRI (natilizumab). ” Biogen seeks a judgment that Sandoz and Polpharma have infringed or will infringe the asserted patents, and preliminary and permanent injunctive relief.

article thumbnail

IP as Collateral

IIPRD

As a result of new technologies, and a rapid increase in innovation and creativity, intellectual capital has emerged as valuable assets for businesses. Intellectual Property such as patents, trademarks, brand value, copyright, etc have become foundational assets for several businesses, seeking greater importance and attention.

IP 40
article thumbnail

[Guest post] Closing the patent loophole across borders

The IPKat

Patents set themselves apart from other IP rights as inventions are often composed of multiple physical components or steps in a method, which does not necessarily have to exist or be performed at the same time and place. has written about this in an article that was recently published in the UIC Review of Intellectual Property Law.

Patent 84